ERNA

ERNEXA THERAPEUTICS INC

ERNA·114082407·US·Common Stock-13D/G

ERNA (ERNEXA THERAPEUTICS INC) is held by 0 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($100,442), VANGUARD FIDUCIARY TRUST CO ($55,434), VANGUARD CAPITAL MANAGEMENT LLC ($37,799). Net institutional sentiment: Bearish.

0
Holders
$0
Total Value
0% (12)
Consensus
0 buying - 12 selling
13F: Insider & Congress: Updated regularly
ERNA

Smart Money Verdict

View all
Loading verdict
Held by 0 funds

Who's Trading

Source dates: Price Aug 21, 2026 · Insiders none · Activists May 20, 2026 · Congress none

ActivistCSClear Street LLC0.0%May 20, 2026
ActivistFRFreebird Partners LP9.9%May 15, 2026
ActivistJDJohn D. Halpern5.6%May 15, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
15,104$100,4420.0%+2116.67%
33
New
8,336$55,4340.0%+2116.67%
32
New
5,684$37,7990.0%+2116.67%
31
New
33$2190.0%+58.33%
17
New
5$330.0%+160.78%
17
New
1$70.0%+58.33%
17
New
0$10.0%-26.92%
17
Exited
0(-100.0%)$10,8130.0%+2116.67%
0
Exited
0(-100.0%)$3,3100.0%+2116.67%
0
Exited
0(-100.0%)$48,6430.0%+701.71%
0
Exited
0(-100.0%)$8,1920.0%+2116.67%
0
Exited
0(-100.0%)$87,1810.0%+312.88%
0
Exited
0(-100.0%)$4,2250.0%+1948.77%
0
ERNAERNAERNEXA THERAPEUTICS INC

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used